Pulling SEC filings + quote and writing the call…

XWELL, Inc.
Next earnings Aug 12, 2026
Last earnings +0.9% on 2026-04-01
Going-concern micro-cap with negative equity, sub-year cash runway and serial dilution — a P/S of 0.3 is a value trap, not a bargain.
Stockholders' equity -$22.3M · FY2025
XWELL is a shrinking, deeply unprofitable personal-services roll-up (XpresSpa airport spas, XpresTest bio-surveillance, Naples Wax) that its own auditors and management flag as a going concern. The 10-K states plainly that 'substantial doubt exists about the Company's ability to continue as a going concern for at least one year,' and the numbers corroborate it: revenue has collapsed from $73.7M (FY2021) to $29.2M (FY2025), down 13.8% in the latest year alone, while the company lost $17.0M net (-58.2% net margin) and burned $8.71M in operating cash. Against that burn — plus $2.96M of capex — sits just $2.62M of cash, itself down 42.5% YoY. That is well under a year of runway, so continued survival depends entirely on raising outside capital.
The balance sheet is already past the point of stress: total liabilities of $23.8M exceed total assets of $11.2M, leaving stockholders' equity at negative $22.3M and a liabilities/equity ratio of -1.07x. Accumulated deficit is -$490M. The company is technically insolvent on a book basis, and current liabilities ($12.9M) are more than double current assets ($5.91M), pointing to a working-capital squeeze on top of the going-concern problem.
Is XWEL a buy? The one-page verdict, explained →
AVOID means we wouldn't engage at all — if expressing the short side anyway, only with capped risk.
Educational template, not a trade recommendation. Strikes and premiums are Black-Scholes model estimates from the last close and 30-day realized volatility — real chains, spreads and IV will differ. Options involve substantial risk.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $73.7M | $55.9M | $30.1M | $33.9M | $29.2M |
| Gross profit | $32.3M | $12.0M | $3.68M | $8.92M | $7.51M |
| Operating income | $4.11M | -$31.2M | -$28.2M | -$16.7M | -$15.7M |
| Net income | $3.35M | -$32.8M | -$27.7M | -$16.9M | -$17.0M |
| Diluted EPS | $0.03 | -$7.01 | -$6.64 | -$3.66 | -$5.08 |
| Net margin | 4.5% | -58.7% | -92.1% | -49.7% | -58.2% |
10-year statements — income, cash flow, balance sheet & CSV export →
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Q1 2026 10-Q: ongoing losses, negative equity, going-concern doubt
NT 10-Q: late-filing notice for Q1 report — filing/controls concern
10-K/A amendment (Part III/disclosures); no new financials
8-K/A amends an earlier disclosure
NT 10-K: late annual-report filing notice — 10-K delayed
NT 10-K: late annual-report filing notice — 10-K delayed
NT 10-K: late annual-report filing notice — 10-K delayed
NT 10-K: late annual-report filing notice — 10-K delayed
New financing + unregistered stock issuance and charter amendment; more dilution
Sources: SEC EDGAR (CIK 0001410428, latest 10-Q filed 2026-05-20) · EODHD · Proprietary analysis · as of 7/4/2026, 9:30:55 AM.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jul 4, 2026, 5:30 AM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
| 2026-02-27 | WEINSTEIN ROBERT Director | Award | 100K | |
| 2026-02-27 | Lebowitz Michael Director | Award | 100K | |
| 2026-02-27 | Ernst Ezra President and CEO | Award | 100K | |
| 2026-02-27 | Bernstein Bruce Director | Award | 100K | |
| 2026-02-27 | Wizenberg Gaelle Sandra Director | Award | 100K | |
| 2025-08-01 | Ernst Ezra President and CEO | Award | 70.0K | |
| 2025-06-02 | Wizenberg Gaelle Sandra Director | Award | 89.2K | |
| 2025-06-02 | Lebowitz Michael Director | Award | 98.1K |
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
1195 tracked peers · median